Data / Form D filings / OWP PHARMACEUTICALS, INC.
OWP PHARMACEUTICALS, INC.: Form D filings
OWP PHARMACEUTICALS, INC., a pharmaceuticals company in Lisle, IL, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on September 9, 2025, reports $2.4 million sold of a $2.4 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 701 WARRENVILLE ROAD, SUITE 200, Lisle, IL, 60532
- Phone
- (847) 722-0803
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Illinois
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2037010
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | New notice | $2,405,000 | $2,405,000 | 19 | Jul 25, 2025 | sec.gov | |
| Sep 16, 2024 | New notice | $2,730,773 | $2,730,773 | 11 | Jun 5, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| TROY HAMMOND | Director | |
| STEVE BOURNE | Executive Officer | |
| MATT LITFIN | Director | |
| KURT FLORIAN | Director | |
| SCOTT BOYER | Executive Officer, Director | |
| BRUCE DUNCAN | Director |
Every Form D from the week of Sep 8, 2025 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what OWP PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.